Clinical Trials
All Clinical Trials - Page 46 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00796289Phase 2Completed
Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females
Gonadorelin
- NCT00744224N/ACompleted
PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide
Exenatide
- NCT01798264Phase 1Completed
Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
Exenatide
- NCT00872378Phase 2/Phase 3Unknown
The Effects of Exenatide After Gastric Restriction
Exenatide
- NCT02090673N/ACompleted
Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea
Exenatide
- NCT00813020Phase 1Completed
A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects
Semaglutide
- NCT00805935Phase 4Completed
Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
Gonadorelin
- NCT00943956Phase 1Completed
Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer
Gonadorelin
- NCT00627406Phase 4Completed
Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles
Gonadorelin
- NCT01311037N/AUnknown
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer
Gonadorelin
- NCT01107717Phase 4Completed
Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM
Exenatide
- NCT00579150N/ATerminated
Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
Exenatide
- NCT01700075Phase 4Completed
Physical and Chemical Study of Atherosclerosis Mechanisms
Exenatide
- NCT00835848Phase 4Completed
Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
Exenatide
- NCT00859534Phase 2Completed
Phase II Solar Urticaria (SU) Pilot Study
Afamelanotide
- NCT00799929N/ACompleted
IVF Clinical Trial of Two Different Treatment Protocols.
Gonadorelin
- NCT00791479Phase 2Completed
Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes
Dulaglutide
- NCT00845507Phase 4Completed
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
Exenatide
- NCT00676338Phase 3Completed
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
Exenatide
- NCT00781937Phase 3Completed
Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance
Liraglutide
- NCT00769795Phase 2Completed
Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer
Ghrp-6
- NCT00788320N/AWithdrawn
Vitamin D in Active Tuberculosis (TB) Study
Ll-37
- NCT00761540Phase 1Completed
To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo
Liraglutide
- NCT00775684N/ACompleted
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
Exenatide
- NCT00765817Phase 3Completed
Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
Exenatide
- NCT00753896Phase 3Completed
Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin
Exenatide
- NCT01389713N/ACompleted
Clomifene Citrate as First Line Treatment in in Vitro Fertilization Cycles for Patients With Lower Ovarian Reserve
Gonadorelin
- NCT00782418Phase 1Completed
A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)
Exenatide
- NCT04425746Phase 2Completed
Afamelanotide as Adjunctive Therapy in Patients Undergoing Photodynamic Therapy (PDT) Utilising Porfimer Sodium
Afamelanotide
- NCT00734474Phase 2/Phase 3Completed
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
Dulaglutide
- NCT00701935Phase 2Terminated
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Exenatide
- NCT00736229Phase 4Completed
Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
Exenatide
- NCT00729326Phase 4Completed
Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
Exenatide
- NCT00845559Phase 4Withdrawn
The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults
Exenatide
- NCT00675506Phase 2Completed
Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
Tesamorelin
- NCT01208649Phase 4Completed
Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
Exenatide
- NCT00717457Phase 3Completed
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Exenatide
- NCT00948168Phase 4Completed
Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes
Exenatide
- NCT00696657Phase 2Completed
A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide
Semaglutide
- NCT00827307N/ACompleted
Zoladex Plus Tamoxifen in Breast Cancer
Gonadorelin
- NCT00700817Phase 3Completed
The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT00855439N/ACompleted
Evaluation of Exenatide in Patients With Diabetic Neuropathy
Exenatide
- NCT00707031Phase 3Completed
GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Exenatide
- NCT00658021Phase 3Completed
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Exenatide
- NCT02012556Phase 1Completed
Pharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive Patients
Tesamorelin
- NCT00711620N/ACompleted
Efficacy of Thymosin alpha1 for Severe Sepsis
Thymosin-Alpha-1
- NCT00630799Phase 3Terminated
Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients
Gonadorelin
- NCT00667069Phase 3Completed
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer
Gonadorelin
- NCT00743769Phase 1Withdrawn
A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers
TB-500
- NCT00672074Phase 2Completed
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
Ipamorelin